Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

What is Cancer?

Cancer is refers to a group of more than a hundred diseases that can originate in many different parts of the body.

What Role do Biobanks Play in Cancer Research?

Is Cancer a Metabolic Disorder?

The Effects of Cancer on Family Life

Cancer Prevention: Lowering your Risk

Cutaneous Manifestations of Internal Malignancy

What is Cancer of Unknown Primary?

Caring for a Loved One with Cancer

British Pioneers in Cancer Biology

Assay for Monitoring and Treating Malignant Brain Tumors

Extracellular Vesicles as Floating Cancer Biomarkers

Microfluidic cancer treatment screen combined with flow cytometry

Overview of Cell Viability and Cytotoxicity

Using Biomarkers to Detect Cancer

Why are Cancer Cell Lines Useful?

Hypoxia Markers and Their Importance

What is the Tumor Microenvironment?

Metastatic Migration in Cancer may be Influenced by Metabolism

The Cancer Cell Surface Proteome as a Therapeutic Target

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

TARDIS: The Improved Method of Detecting Breast Cancer

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Investigating the Molecular Mechanisms of Cancer

Acidosis and Tumor Progression

What is Merkel Cell Carcinoma?

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

The Biochemistry of Breast Cancer Screening

Hot vs Cold: the differences between tumor types

Transforming Cancer Care through Genomic Testing

Exploiting Enzymes in Cancer Diagnosis and Therapy

Latest Cancer News and Research

First UK real-world study shows promise for sacituzumab govitecan in metastatic breast cancer

The real-world safety and efficacy of sacituzumab govitecan (SG) against metastatic triple-negative breast cancer.

26 Apr 2024

How body shape influences colorectal cancer risk

Study reveals that specific body shape phenotypes, such as general obesity and central obesity, significantly increase the risk of colorectal cancer, suggesting distinct molecular pathways for different adiposity subtypes.

25 Apr 2024

Cancer history raises cardiovascular disease risk in hypertensive patients

Research reveals that individuals with hypertension and a history of cancer are at an increased risk of cardiovascular disease, with those undergoing chemotherapy facing the highest risk.

25 Apr 2024

New research lays foundation for targeted therapies to inhibit NF-κB activation

A new paper by Dana-Farber Cancer Institute scientists lays the foundation for targeted therapies to inhibit activation of nuclear factor kappa B (NF-κB), a transcription factor that plays a role in various autoimmune and inflammatory diseases and cancers.

25 Apr 2024

Loneliness increases mortality risk in cancer survivors, study finds

A new study led by researchers at the American Cancer Society (ACS) showed people surviving cancer who reported feeling more lonely experienced a higher mortality risk compared to survivors reporting low or no loneliness.

25 Apr 2024

MIT study reveals circadian impact on drug metabolism in engineered livers

Giving drugs at different times of day could significantly affect how they are metabolized in the liver, according to a new study from MIT.

25 Apr 2024

Study finds rise in volumes and survival after hematopoietic cell transplants among racial/ethnic minorities

The volume of hematopoietic cell transplants rose among all racial/ethnic groups, but grew faster among African Americans and Hispanics compared with Non-Hispanic white individuals, mirroring changes in population growth rates.

25 Apr 2024

Insilico Medicine's AI-designed drug ISM3412 receives FDA IND approval

Clinical stage artificial intelligence (AI)-driven drug discovery company Insilico Medicine announces that it has received approval from the U.S. Food and Drug Administration for its Investigational New Drug application for ISM3412, a small molecule inhibitor of MAT2A for the potential treatment of MTAP deleted cancers designed with Insilico's generative AI platform.

25 Apr 2024

154 million lives saved: Landmark study highlights power of vaccination

A major landmark study to be published by The Lancet reveals that global immunization efforts have saved an estimated 154 million lives – or the equivalent of 6 lives every minute of every year – over the past 50 years.

25 Apr 2024

DELiVR's virtual reality training speeds up cell detection in complex brain datasets

Efficient neuronal activity detection in brain imaging.

25 Apr 2024

Genetics studies have a diversity problem that researchers struggle to fix

When he recently walked into the dental clinic at the Medical University of South Carolina donning a bright-blue pullover with "In Our DNA SC" embroidered prominently on the front, Lee Moultrie said, two Black women stopped him to ask questions.

25 Apr 2024

Therapeutic potential of human umbilical cord-derived mesenchymal stem cells in Crohn’s disease

Whether human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) could heal luminal ulcers in Crohn’s disease.

25 Apr 2024

Meta-analysis reveals drivers of antibiotic resistance in infants

A meta-analysis of genetic studies analyzing the microbiota (bacteria in the gut) of 1,275 infants from 10 countries finds that cesarean delivery and antibiotic use are driving the increase of antibiotic resistance genes load among infants, according to new research being presented at this year's ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April).

24 Apr 2024

New system personalizes chemotherapy doses for cancer patients

When cancer patients undergo chemotherapy, the dose of most drugs is calculated based on the patient's body surface area. This is estimated by plugging the patient's height and weight into an equation, dating to 1916, that was formulated from data on just nine patients.

24 Apr 2024

Study links acid-reducing drugs to increased risk of migraine

People who take acid-reducing drugs may have a higher risk of migraine and other severe headache than people who do not take these medications, according to a study published in the April 24, 2024, online issue of Neurology Clinical Practice, an official journal of the American Academy of Neurology.

24 Apr 2024

Breast cancer survivors at higher risk of developing second cancers

Survivors of breast cancer are at significantly higher risk of developing second cancers, including endometrial and ovarian cancer for women and prostate cancer for men, according to new research studying data from almost 600,000 patients in England.

24 Apr 2024

Public health experts urge universities and schools to ban alcohol industry-funded education programs

Public health experts are calling for a ban on alcohol industry-funded education programmes in UK universities and schools, which they say normalise drinking and downplay the long-term health risks of alcohol.

24 Apr 2024

Opportunities and limitations of using a large language model to respond to patient messages

A new study by investigators from Mass General Brigham demonstrates that large language models (LLMs), a type of generative AI, may help reduce physician workload and improve patient education when used to draft replies to patient messages.

24 Apr 2024

Research reveals potential target for enfortumab vedotin therapy in urothelial carcinoma

Under the leadership of PD Dr. Niklas Klümper, Assistant Physician at the Department of Urology at the University Hospital Bonn (UKB) and Clinician Scientist of the BMBF-funded ACCENT program and PD Dr. Markus Eckstein, senior physician at the Institute of Pathology at the Uniklinikum Erlangen of the Friedrich-Alexander-University Erlangen-Nürnberg (FAU), an interdisciplinary research team has published new findings that indicate which patients with advanced urothelial carcinoma could benefit in particular from the new targeted therapy with the antibody-drug conjugate enfortumab vedotin.

24 Apr 2024

CASGEVY gene therapy eliminates vaso-occlusive crises in sickle cell patients

In a landmark study, an international consortium led by researchers at Children's Hospital of Philadelphia (CHOP) published the final results of a key clinical trial of the gene therapy CASGEVY (exagamglogene autotemcel) for the treatment of sickle cell disease in patients 12 years and older with recurrent vaso-occlusive crises (VOCs).

24 Apr 2024